From his presentation, Dr. Murthy seems to be behind on “finishing” and “validating” for commercial automation. Did you get a different read from your discussion with Dr. Murthy? Did you get any sense of timeline?
Did you get a sense from Dr. Bosch whether they thought it might be possible to begin commercial manufacturing (if DCVax-l approvable) with manual production and then transition to automated?
Market Data 
Markets 
AI
